SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-431609
Filing Date
2013-11-07
Accepted
2013-11-07 08:18:50
Documents
12
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d599634d10q.htm 10-Q 618502
2 EX-12 d599634dex12.htm EX-12 26473
3 EX-31.1 d599634dex311.htm EX-31.1 8897
4 EX-31.2 d599634dex312.htm EX-31.2 8893
5 EX-32.1 d599634dex321.htm EX-32.1 3918
6 EX-32.2 d599634dex322.htm EX-32.2 3951
  Complete submission text file 0001193125-13-431609.txt   3567945

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT alny-20130930.xml EX-101.INS 519813
8 XBRL TAXONOMY EXTENSION SCHEMA alny-20130930.xsd EX-101.SCH 30410
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE alny-20130930_cal.xml EX-101.CAL 38854
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE alny-20130930_def.xml EX-101.DEF 151515
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE alny-20130930_lab.xml EX-101.LAB 245716
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alny-20130930_pre.xml EX-101.PRE 173637
Mailing Address 300 THIRD STREET CAMBRIDGE MA 02142
Business Address 300 THIRD STREET CAMBRIDGE MA 02142 (617) 551-8200
ALNYLAM PHARMACEUTICALS, INC. (Filer) CIK: 0001178670 (see all company filings)

IRS No.: 770602661 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50743 | Film No.: 131198556
SIC: 2834 Pharmaceutical Preparations